• Home
  • Services
  • Team
  • Payment
  • Contact Us
  • Home
  • Services
  • Team
  • Payment
  • Contact Us
On June 20, 2011

Valeant, an Aggressive Buyer of Drug Companies, Acquires Its Way to Mediocrity

Could Valeant be growing up, and in so doing turning into just another boring old drug company? Its numbers suggest that’s exactly what’s happening: It’s acquiring its way to mediocrity.

No tags for this post.


  • By admin  0 Comments 
  • 0 Comments

    © 2023 Business Architects, Inc. All rights reserved. info@bizarchitects.com. Designed by Abel Creative Group.